This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 W Wilson , R D'Agostino , H Parise , (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066–3072.
2 J Dekker , C Girman , T Rhodes , (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112, 666–673.
3 E Ford , W Giles & W Dietz (2002) Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359.
4 RC Ruhe & RB McDonald (2001) Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20, 363S–369S, .
5 ES Ford , JC Will , BA Bowman , (1999) Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 149, 168–176.
7 K Suzuki , Y Ito , S Nakamura , (2002) Relationship between serum carotenoids and hyperglycemia: a population-based cross-sectional study. J Epidemiol 12, 357–366.
9 A D'Odorico , D Martines , S Kiechl , (2000) High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis. Results from the Bruneck Study. Atherosclerosis 153, 231–239.
11 ML Daviglus , AJ Orencia , AR Dyer , (1997) Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study. Neuroepidemiology 16, 69–77.
12 A Hozawa , DR Jacobs Jr, MW Steffes , (2009) Circulating carotenoid concentrations and incident hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Hypertens 27, 237–242.
13 E Giovannucci , EB Rimm , Y Liu , (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391–398.
14 A D'Odorico , S Bortolan , R Cardin , (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36, 1289–1294.
19 ES Ford , AH Mokdad , WH Giles , (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52, 2346–2352.
21 PL Lutsey , LM Steffen & J Stevens (2008) Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities Study. Circulation 117, 754–761.
22 S Liu , U Ajani , C Chae , (1999) Long-term beta-carotene supplementation and risk of type2 diabetes mellitus: a randomised controlled trial. JAMA 282, 1073–1075.
25 DW Dunstan , PZ Zimmet , TA Welborn , (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25, 829–834.
26 DW Dunstan , PZ Zimmet , TA Welborn , (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) – methods and response rates. Diabetes Res Clin Pract 57, 119–129.
28 D Talwar , TK Ha , J Cooney , (1998) A routine method for the simultaneous measurement of retinol, alpha-tocopherol and five carotenoids in human plasma by reverse phase HPLC. Clin Chim Acta 270, 85–100.
29 K Alberti , PZ Zimmet & JE Shaw (2006) Metabolic syndrome – a new world-wide definition. A concensus statement from the International Diabetes Federation. Diabet Med 23, 469–480.
35 A Hozawa , DR Jacobs Jr, MW Steffes , (2006) Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 163, 929–937.
36 J Redon , M Oliva , C Tormos , (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096–1101.
37 S Furukawa , T Fujita , M Shimabukuro , (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752–1761.
38 B Hansel , P Giral , E Nobecourt , (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89, 4963–4971.
39 J Montonen , P Knekt , R Jarvinen , (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27, 362–366.
40 L Sargent , K Khaw , S Bingham , (2001) Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC–Norfolk Study. Eur J Clin Nutr 55, 342–348.
41 J Tuomilehto , J Lindstrom , J Eriksson , (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 344, 1343–1350.
42Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 346, 393–403.